For this quarter’s funding analysis, let’s examine how average funding in the health technology sector is evolving. The graphic below shows the health technology average funding across all deals over time by quarter.
As the graphic demonstrates, health technology average funding deal size in Q1 2019 was at $42M, which increased by 30% from the $32M last quarter. The average funding deal size has demonstrated strong upward growth, with the average funding last quarter around 5 times larger than it was 5 years ago. The top three funding events in Q1 2019 include a $1B round into Verily, a $500M round into Clover Health, and a $299M round into BridgeBio.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.